Advertisement

Inflammatory and immune mediated sensory neuropathies

  • R. A. C. Hughes
Conference paper

Summary

Human sensory neuropathies having an inflammatory component or presumed immune pathogenesis are reviewed. Sensory forms of acute (Miller Fisher syndrome) and chronic idiopathic demyelinating polyradiculoneuropathy are probably due to autoimmune responses against antigens relatively restricted to the myelin of sensory nerves. Subacute sensory neuronopathy associated with small cell carcinoma of the lung is caused by dorsal root ganglionitis: an antibody against a neuronal nuclear antigen is characteristically present in this syndrome and may be important in pathogenesis. Similar mechanisms might explain the dorsal root ganglionitis associated with Sjögren’s syndrome and the inflammation of the trigeminal ganglion which is thought to underlie benign trigeminal neuropathy. Nonspecific inflammatory disorders, including amyloid deposition, granulomas associated with leprosy or sarcoidosis, and vasculitis, also produce sensory neuropathy. The leakiness of the blood-nerve barrier and the presence of satellite cells expressing MHC class II antigen in the dorsal root ganglion may contribute to the susceptibility of sensory nerves to autoimmune damage.

Keywords

Dorsal Root Ganglion Sensory Neuropathy Mixed Connective Tissue Disease Lepromatous Leprosy Miller Fisher Syndrome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Anderson NE, Rosenblaum MK, Graus F, Wiley RG, Posner JB (1988) Autoantibodies in paraneoplastic syndromes associated with small-cell lung cancer. Neurology 38: 1391–1398PubMedCrossRefGoogle Scholar
  2. 2.
    Cornblath DR, McArthur JC (1988) Predominantly sensory neuropathy in patients with AIDS and AIDS-related complex. Neurology 38: 794–796PubMedCrossRefGoogle Scholar
  3. 3.
    Cornblath DR, Albers JW, Feasby TE, Hahn AF, McLeod JG, Mendell JR, et al (1991) Chronic inflammatory demyelinating polyneuropathy (CIDP): proposed criteria for diagnosis. Neurology 41: 617–618CrossRefGoogle Scholar
  4. 4.
    De la Monte SM, Gabuzda DH, Ho DH, Brown RH, Hedley-White ET, Schooley RT, et al (1988) Peripheral neuropathy in the acquired immunodeficiency syndrome. Ann Neurol 23: 485–492PubMedCrossRefGoogle Scholar
  5. 5.
    Denny-Brown D (1948) Primary sensory neuropathy with muscular changes associated with carcinoma. J Neurol Neurosurg Psychiatry 11: 73–87PubMedCrossRefGoogle Scholar
  6. 6.
    Dyck PJ, Berstead TJ, Conn DL, Stevens JC, Windebank AJ, Low PA (1987) Non-systemic vasculitic neuropathy. Brain 110: 843–854PubMedCrossRefGoogle Scholar
  7. 7.
    Dyck PJ, Lais AC, Ohta M, Bastron JA, Okazaki H, Groover RV (1975) Chronic inflammatory polyradiculoneuropathy. Mayo Clin Proc 50:621–651PubMedGoogle Scholar
  8. 8.
    Elder G, Dalakas M, Pezeshkpour G, Sever J (1986) Ataxic neuropathy due to ganglioneuronitis after probable acute human immunodeficiency virus infection. Lancet 2: 1275–1276PubMedCrossRefGoogle Scholar
  9. 9.
    Esiri MM, Reading MC (1989) Macrophages, lymphocytes and major histocompatability complex (HLA) class II antigens in adult human sensory and sympathetic ganglia. J Neuroimmunol 23: 187–193PubMedCrossRefGoogle Scholar
  10. 10.
    Fisher M (1956) Syndrome of ophthalmoplegia, ataxia and areflexia. N Engl J Med 255: 57–65PubMedCrossRefGoogle Scholar
  11. 11.
    Fross RD, Daube J (1987) Neuropathy in the Miller-Fisher syndrome: clinical and electrophysiologic findings. Neurology 37: 1493–1498PubMedCrossRefGoogle Scholar
  12. 12.
    Gainsborough N, Hall SM, Hughes RAC, Leibowitz S (1991) Sarcoid neuropathy. J Neurol 238: 177–180PubMedCrossRefGoogle Scholar
  13. 13.
    Graus F, Cordon-Cardo C, Posner JB (1985) Neuronal antinuclear antibody in sensory neuronopathy from lung cancer. Neurology 35: 538–543PubMedCrossRefGoogle Scholar
  14. 14.
    Graus F, Elkon KB, Cordon-Cardo C, Posner JB (1986) Sensory neuronopathy and small cell lung cancer. Antineuronal antibody that also reacts with the tumour. Am J Med 80: 45–52PubMedCrossRefGoogle Scholar
  15. 15.
    Griffin JW, Cornblath DR, Alexander E, Campbell J, Low PA, Bird S, et al (1990) Ataxic sensory neuropathy and dorsal root ganglionitis associated with Sjögren’s syndrome. Ann Neurol 27: 304–315PubMedCrossRefGoogle Scholar
  16. 16.
    Guiloff RJ (1977) Peripheral nerve conduction in Miller Fisher syndrome. J Neurol Neurosurg Psychiatry 40: 801–807PubMedCrossRefGoogle Scholar
  17. 17.
    Hanyu N, Ikeda S, Nakadai A, Yanagisawa N, Powell HC (1989) Peripheral nerve pathological findings in familial amyloid polyneuropathy: a correlative study of proximal sciatic nerve and sural nerve lesions. Ann Neurol 25: 34–350CrossRefGoogle Scholar
  18. 18.
    Hughes RAC (1990) Guillain-Barré Syndrome. Springer: HeidelbergGoogle Scholar
  19. 19.
    Hughes RAC, Atkinson PF, Gray IA, Taylor WA (1987a) Major histocompatibility antigens and lymphocyte subsets during experimental allergic neuritis in the Lewis rat. J Neurol 234: 390–395PubMedCrossRefGoogle Scholar
  20. 20.
    Hughes RAC, Sanders EACM, Winer JB (1987b) Guillain-Barré syndrome and chronic idiopathic demyelinating polyradiculoneuropathy. Prog Clin Neurosci 1: 143–155Google Scholar
  21. 21.
    Jacobs JM, MacFarlane RM, Cavanagh JB (1976) Vascular leakage in the dorsal root ganglia of the rat, studied with horseradish perioxidase. J Neurol Sci 29: 95–107PubMedCrossRefGoogle Scholar
  22. 22.
    Kadlubowski M, Hughes RAC, Gregson NA (1984) Spontaneous and experimental neuritis and the distribution of the myelin protein P2 in the nervous system. J Neurochem 42: 123–129PubMedCrossRefGoogle Scholar
  23. 23.
    Kaltreider HB, Talal N (1969) The neuropathy of Sjögren’s syndrome: trigeminal nerve involvement. Ann Intern Med 70: 751–762PubMedGoogle Scholar
  24. 24.
    Laloux P, Brucher JM, Guerit JM, Sindic CJM, Laterre EC (1988) Subacute sensory neuropathy associated with Sjögren’s sicca syndrome. J Neurol 235: 352–354PubMedCrossRefGoogle Scholar
  25. 25.
    Lecky BRF, Hughes RAC, Murray NMF (1987) Trigeminal sensory neuropathy. A study of 22 cases. Brain 110: 1463–1485PubMedCrossRefGoogle Scholar
  26. 26.
    Mellgren SI, Conn DL, Stevens JC, Dyck PJ (1989) Peripheral neuropathy in primary Sjögren’s syndrome. Neurology 39: 390–394PubMedCrossRefGoogle Scholar
  27. 27.
    Phillips MS, Stewart S, Anderson JR (1984) Neuropathological findings in Miller-Fisher syndrome. J Neurol Neurosurg Psychiatry 47: 492–495PubMedCrossRefGoogle Scholar
  28. 28.
    Pollard JD, McLeod JG (1990) Chronic inflammatory demyelinating polyradiculoneuropathy presenting as a sensory neuropathy. Peripheral Neuropathy Association Meeting, p 20 (Abstract)Google Scholar
  29. 29.
    Posner JB, Furneaux HM (1990) Paraneoplastic syndromes. In: Waksman BH (ed) Immunologic mechanisms in neurologic and psychiatric disease. Raven Press: New York, pp 187–219Google Scholar
  30. 30.
    Powell HC, Braheny SL, Hughes RAC, Lampert PW (1984) Antigenspecific demyelina-tion and significance of the bystander effect in peripheral nerves. Am J Pathol 114: 443–453PubMedGoogle Scholar
  31. 31.
    Quarles RH, Daune GC, Willison HJ, Baba H, Ilyas AA, Dalakas MC, et al (1990) Variation of antibody specificities in neuropathy patients with antibodies to myelin-associated glycoprotein or to GM1 ganglioside. Peripheral Neuropathy Association Meeting, p 76 (Abstract)Google Scholar
  32. 32.
    Said G, Lacroix-Ciaudo C, Fujimura H, Blas C, Faux N (1988) The peripheral neuropathy of necrotising arteritis: a clinicopathological study. Ann Neurol 23: 461–465PubMedCrossRefGoogle Scholar
  33. 33.
    Shetty VP, Antia NH, Jacobs JM (1988) The pathology of early leprous neuropathy. J Neurol Sci 88: 115–132PubMedCrossRefGoogle Scholar
  34. 34.
    Sterman AB, Schaumburg HH, Asbury AK (1980) The acute sensory neuronopathy syndrome: a distinct clinical entity. Ann Neurol 7: 354–358PubMedCrossRefGoogle Scholar
  35. 35.
    Younes-Chennoufi AB, Leger JM, Lubetzki C, Ratinahirana H, Bouche P, Harpin ML, et al (1990) Gangliosides GD1a and GD1b are target antigens for monoclonal IgM in predominantly sensory polyneuropathy. J Neurol 237 [Suppl 1]: S 9Google Scholar

Copyright information

© Springer-Verlag Wien 1995

Authors and Affiliations

  • R. A. C. Hughes
    • 1
  1. 1.Department of NeurologyUnited Medical and Dental Schools of Guy’s and St. Thomas’s HospitalsLondonUK

Personalised recommendations